1. Home
  2. MTG vs RGEN Comparison

MTG vs RGEN Comparison

Compare MTG & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MGIC Investment Corporation

MTG

MGIC Investment Corporation

HOLD

Current Price

$31.22

Market Cap

6.3B

Sector

Finance

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$167.57

Market Cap

6.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MTG
RGEN
Founded
1957
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.3B
6.6B
IPO Year
2008
1995

Fundamental Metrics

Financial Performance
Metric
MTG
RGEN
Price
$31.22
$167.57
Analyst Decision
Hold
Buy
Analyst Count
4
12
Target Price
$28.50
$167.67
AVG Volume (30 Days)
1.4M
936.5K
Earning Date
04-29-2026
05-05-2026
Dividend Yield
2.06%
N/A
EPS Growth
8.65
286.96
EPS
1.62
0.24
Revenue
$1,213,636,000.00
$141,236,000.00
Revenue This Year
$2.50
$14.30
Revenue Next Year
$1.77
$14.52
P/E Ratio
$19.47
$701.96
Revenue Growth
0.49
35.10
52 Week Low
$24.69
$100.99
52 Week High
$31.89
$188.73

Technical Indicators

Market Signals
Indicator
MTG
RGEN
Relative Strength Index (RSI) 65.79 51.33
Support Level $25.57 $156.65
Resistance Level $31.62 $173.10
Average True Range (ATR) 0.38 7.57
MACD -0.07 -1.91
Stochastic Oscillator 97.38 15.97

Price Performance

Historical Comparison
MTG
RGEN

About MTG MGIC Investment Corporation

MGIC Investment Corp provides private mortgage insurance, other mortgage credit risk management solutions, and ancillary services. The insurance premiums that these customers pay for the protection account for close to the majority of the company's total revenue. Investment income accounts for the remaining revenue. The company sells its insurance products in all states of the United States and in Puerto Rico. Its greatest exposure is in California, Florida, Texas, Pennsylvania, Ohio, Illinois, Virginia, North Carolina, Georgia, and New York.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: